Are you
- At risk for bladder cancer such as: Smoking, Exposure to certain occupational and environmental chemicals, Chronic bladder inflammation, Previous cancer treatment with cyclophosphamide or radiation?
- Experiencing urinary irritation or changes in bladder habits?
- Concerned if you find blood in your urine?
- In need of a diagnosis for urothelial carcinoma (UC)?
- Facing a negative urine cytology or unknown radiographic diagnosis?
- Unable to accept or unsuited for cystoscopy or ureteroscopy?
If yes, The AcornUI-SEEK Test may be right for you.
What is the AcornUI-SEEK?
AcornUI-SEEK is a test used to evaluate a patient's risk of UC. It detects four genes (TERT, FGFR3, ONECUTE2, VIM) and delivers exceptional performance, providing valuable results. This simple, objective, urine-based test demonstrates high sensitivity and specificity. It can help reassure patients by providing an accurate, quick, and economical diagnosis to rule in or rule out UC.
What are the benefits of the AcornUI-SEEK?
AcornUI-SEEK helps you and your urologist to better understand your individual risk of UC and determine whether you should undergo a cystoscopy or ureteroscopy.
It is non-invasive, and easy-to-use. There's no need to visit the hospital. You only need to collect a urine sample at home and deliver it to us.
How to order the test?
AcornUI-SEEK test results
AcornUI-SEEK provides a personalized risk score for you.
Results are usually written as "positive" or "negative".
- A positive result indicates a high risk of bladder cancer, ureteral cancer or renal pelvic cancer. It is recommended to follow your doctor's advice, consider the results of other tests for a comprehensive evaluation, and schedule associated examinations if necessary.
- A negative result indicates a low risk of bladder cancer, ureteral cancer or renal pelvic cancer. It is advisable to consult your clinical doctor, maintain healthy lifestyle habits, and undergo regular physical examinations.
Terminology
Understanding the definitions of the following medical terms can enhance your communication with urologists.
Terminology |
Definition |
Urothelial carcinoma |
A malignant tumor originates from the urothelium, which can occur in any part of the urinary tract lined by urothelium, primarily including the renal pelvis, ureter, bladder, etc. |
Clinical trial |
A scientific study involving patients with specific diseases to evaluate drugs or procedures. The results of clinical trials are typically reviewed by medical experts and published in scientific journals |
Cystoscopy |
Cystoscopy is an endoscopic examination that allows a doctor to inspect the interior of the bladder and urethra by inserting a hollow tube equipped with a lens into the urethra. |
Ureteroscopy |
Ureteroscopy is an endoscopic examination where a thin, elongated ureteroscope (a type of medical endoscope) is inserted through the urethra into the ureter to directly observe the interior of the ureter for diagnostic purposes. |
Gene |
The basic unit carrying genetic information within a living organism, composed of DNA molecules. |
Hematuria |
The presence of blood in the urine. |
Gross hematuria |
Urine that appears red, like the color of diluted blood, dark like tea or other abnormal color, sometimes containing blood clots, visible to the naked eye. |
Microscopic hematuria |
It refers to the presence of red blood cells in the urine in amounts exceeding normal levels, detectable only under a microscope, while the urine appears normal in color. |